Pfizer Inc. buy BMO Capital Markets
Start price
23.06.26
/
50%
€21.91
Target price
23.06.27
-
Performance (%)
2.37%
Price
18:00
€22.43
Summary
This prediction is currently active. With a performance of 2.37%, the BUY prediction by BMO_Capital_Markets for Pfizer Inc. is trending in the right direction. This prediction currently runs until 23.06.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 1.592% | 1.592% |
| iShares Core DAX® | 3,15 % | 1,50 % |
| iShares Nasdaq 100 | 7,43 % | -1,58 % |
| iShares Nikkei 225® | 8,57 % | -4,32 % |
| iShares S&P 500 | 4,58 % | 1,92 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (PFE) had its "outperform" rating reaffirmed by BMO Capital Markets.
Ratings data for PFE provided by MarketBeat

